AGC Biologics to Support Teikoku Seiyaku’s KTP-001 Seattle-based AGC Biologics has been selected by Japanese pharmaceutical company Teikoku Seiyaku to provide microbial contract development and manufacturing services for KTP-001, a recombinant human matri... See more
The Pacific Coast Part 1: AI and Drug Discovery Intersect in the Pacific Northwest The Pacific Northwest is rapidly advancing as a center for AI-driven drug discovery through coordinated federal initiatives, startup investment, and expanding research infr... See more
2026 GeekWire Awards revealed: Big winners — and big love for Seattle — at annual tech celebration Life sciences and health innovation companies were among the organizations recognized at the 2026 GeekWire Awards, highlighting the growing influence of Was... See more
